Ruben Dario Arizola García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ruben Dario Arizola García has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Gisela Berenice Orozco Torres
Instituto Mexicano del Seguro Social
2 shared publications - Carlos Vargas Oliva
Instituto Mexicano del Seguro Social
1 shared publication - David Antonio Ramírez Pérez
Instituto Tecnologico y de Estudios Superiores de Monterrey
1 shared publication - José de la Luz Pérez Castro
Universidad Michoacana de San Nicolás de Hidalgo
1 shared publication - Mario Alberto Zuñiga Rios
Instituto Mexicano del Seguro Social
1 shared publication - Miguel Ángel Gutiérrez Galindo
Universidad de Guanajuato
1 shared publication
Latest Publications
- Open Access
- 13 July 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (3) , 1189-1196
Asociación entre los Niveles de HBA1C y el Grado de Retinopatía Determinado por Cámara de Inteligencia Artificial en los Pacientes con Diabetes Mellitus Tipo 2 Adscritos a la UMF 47 de León Guanajuato
Background. Retinopathy is an ocular complication related to diabetes mellitus that affects the retina, the light-sensitive tissue layer at the back of the eye. This condition occurs due to damage caused by elevated and poorly controlled blood glucose levels over a prolonged period, which can damage the blood vessels of the retina. In Mexico, approximately 31.5% of patients suffer from this condition. General Objective. To evaluate the association between HbA1c levels and the degree of retinopathy as determined by an artificial intelligence camera in patients with type 2 diabetes mellitus registered at Family Medicine Unit 47 in León, Guanajuato. Materials and methods. A quantitative, observational, retrospective, and cross-sectional study was conducted with an analytical cross-sectional design. The sample size was calculated using the formula for proportions in an infinite population, considering a 99% confidence level, a 5% margin of error, and an expected retinopathy prevalence of 31.5%, resulting in a sample size of 573 participants. Sampling was carried out using a simple random probability method. For the analytical statistical analysis, specific tests were used according to the characteristics of the data. For the comparison of proportions between two variables in patients with type 2 diabetes mellitus, the chi-square test or Fisher's exact test was used, as appropriate. A p-value < 0.05 was considered statistically significant. Results: A statistically significant association was identified between elevated glycated hemoglobin (HbA1c) levels and greater severity of diabetic retinopathy (p < 0.001). Likewise, a longer duration of type 2 diabetes mellitus was associated with more advanced stages of retinopathy (p < 0.001). The disease was present in both sexes with no significant differences. The age group was primarily around 63 years. Among comorbidities, hypertension was the most frequent, present in 73% of patients, followed by renal insufficiency in 4.5%. Conclusion: Elevated HbA1c levels and a longer duration of type 2 diabetes mellitus were associated with more severe stages of diabetic retinopathy. Hypertension was the most frequent comorbidity, and no significant differences were observed between sexes. These results highlight the need to strengthen glycemic control, comprehensive management of comorbidities, and timely screening with the support of artificial intelligence, in order to promote early detection and timely ophthalmological referral.
- 13 July 2026
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 5 (3) , 1189-1196
Open AccessAsociación entre los Niveles de HBA1C y el Grado de Retinopatía Determinado por Cámara de Inteligencia Artificial en los Pacientes con Diabetes Mellitus Tipo 2 Adscritos a la UMF 47 de León Guanajuato
Background. Retinopathy is an ocular complication related to diabetes mellitus that affects the retina, the light-sensitive tissue layer at the back of the eye. This condition occurs due to damage caused by elevated and poorly controlled blood glucose levels over a prolonged period, which can damage the blood vessels of the retina. In Mexico, approximately 31.5% of patients suffer from this condition. General Objective. To evaluate the association between HbA1c levels and the degree of retinopathy as determined by an artificial intelligence camera in patients with type 2 diabetes mellitus registered at Family Medicine Unit 47 in León, Guanajuato. Materials and methods. A quantitative, observational, retrospective, and cross-sectional study was conducted with an analytical cross-sectional design. The sample size was calculated using the formula for proportions in an infinite population, considering a 99% confidence level, a 5% margin of error, and an expected retinopathy prevalence of 31.5%, resulting in a sample size of 573 participants. Sampling was carried out using a simple random probability method. For the analytical statistical analysis, specific tests were used according to the characteristics of the data. For the comparison of proportions between two variables in patients with type 2 diabetes mellitus, the chi-square test or Fisher's exact test was used, as appropriate. A p-value < 0.05 was considered statistically significant. Results: A statistically significant association was identified between elevated glycated hemoglobin (HbA1c) levels and greater severity of diabetic retinopathy (p < 0.001). Likewise, a longer duration of type 2 diabetes mellitus was associated with more advanced stages of retinopathy (p < 0.001). The disease was present in both sexes with no significant differences. The age group was primarily around 63 years. Among comorbidities, hypertension was the most frequent, present in 73% of patients, followed by renal insufficiency in 4.5%. Conclusion: Elevated HbA1c levels and a longer duration of type 2 diabetes mellitus were associated with more severe stages of diabetic retinopathy. Hypertension was the most frequent comorbidity, and no significant differences were observed between sexes. These results highlight the need to strengthen glycemic control, comprehensive management of comorbidities, and timely screening with the support of artificial intelligence, in order to promote early detection and timely ophthalmological referral.
- Open Access
- 18 October 2025
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 4 (4) , 4017-4035
Perfil Clínico Epidemiológico de los Pacientes con Cáncer de Próstata Adscritos a la UMF N° 47 en el Periodo del 2019 a 2023
The study aimed to determine the clinical-epidemiological profile of patients with prostate cancer assigned to Family Medicine Unit No. 47 during the 2019–2023 period. It sought to describe their clinical characteristics, associated factors, and diagnostic patterns to generate information that contributes to improving timely detection and management of this disease. Prostate cancer is the second leading cause of cancer-related death in men worldwide and nationally. In Mexico, it maintains a high incidence, highlighting the importance of early detection as a strategy to intervene in initial stages and improve prognosis. The study used a quantitative approach with an observational, retrospective, cross-sectional, and descriptive design. Records from 159 confirmed patients were reviewed, analyzing sociodemographic, clinical, and diagnostic variables through descriptive statistics. The average age was 75.2 years, with most patients being retired men and having normal weight. Hypertension was the most frequent comorbidity. Prostate-specific antigen was the most commonly used diagnostic study, while urinary urgency was the most common symptom. The results emphasized the need to strengthen screening programs for men over 50 years of age and those with risk factors. They also highlighted the importance of promoting health education, reducing stigma, and encouraging a comprehensive approach that improves prognosis and quality of life.
- 18 October 2025
- Published by Editorial Ibero Ciencias in Ibero Ciencias - Revista Científica y Académica
- Vol. 4 (4) , 4017-4035
Open AccessPerfil Clínico Epidemiológico de los Pacientes con Cáncer de Próstata Adscritos a la UMF N° 47 en el Periodo del 2019 a 2023
The study aimed to determine the clinical-epidemiological profile of patients with prostate cancer assigned to Family Medicine Unit No. 47 during the 2019–2023 period. It sought to describe their clinical characteristics, associated factors, and diagnostic patterns to generate information that contributes to improving timely detection and management of this disease. Prostate cancer is the second leading cause of cancer-related death in men worldwide and nationally. In Mexico, it maintains a high incidence, highlighting the importance of early detection as a strategy to intervene in initial stages and improve prognosis. The study used a quantitative approach with an observational, retrospective, cross-sectional, and descriptive design. Records from 159 confirmed patients were reviewed, analyzing sociodemographic, clinical, and diagnostic variables through descriptive statistics. The average age was 75.2 years, with most patients being retired men and having normal weight. Hypertension was the most frequent comorbidity. Prostate-specific antigen was the most commonly used diagnostic study, while urinary urgency was the most common symptom. The results emphasized the need to strengthen screening programs for men over 50 years of age and those with risk factors. They also highlighted the importance of promoting health education, reducing stigma, and encouraging a comprehensive approach that improves prognosis and quality of life.